Skip to main content
MyCapitol LogoMyCapitol

S 1214 · 118th Congress

RARE Act

The RARE Act clarifies how long pharmaceutical companies get exclusive rights to sell drugs designed for rare diseases. When a drug is approved to treat a rare disease, the FDA currently gives the company a seven-year period where no competitor can sell the same drug for that disease. However, there's been confusion…

Sponsor
Baldwin, Tammy (D-WI)
Introduced
2023-04-19
Policy area
Health
Latest action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 109.

Digging through Congress... 🔍